Welcome to our dedicated page for Accendra Health SEC filings (Ticker: ACH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Accendra Health, Inc. filings document operating results, material events and capital-structure matters for a NYSE-listed home healthcare company with common stock trading under ACH. Form 8-K reports furnish quarterly and annual financial results and record material agreements, shareholder voting matters and balance-sheet disclosures.
Proxy materials describe governance, executive compensation and related shareholder matters. The filings also identify the company as a Virginia corporation and provide formal disclosure around its continuing operations following the completed sale of its former Products & Healthcare Services business.
Accendra Health Inc. received a Schedule 13G from Charles Schwab Investment Management Inc. showing a significant institutional position in its common stock. Charles Schwab Investment Management reports beneficial ownership of 4,057,056 shares, representing 5.24% of the outstanding common stock as of the triggering date.
The filing states that Schwab has sole voting and sole dispositive power over all 4,057,056 shares, with no shared voting or dispositive authority. Schwab certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Accendra Health.